1,177 research outputs found
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
Streptococcus pneumoniae serotype 1 is the predominant cause of invasive pneumococcal disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not well understood. Here, we use mouse models of lung infection to identify virulence factors associated with severe bacteraemic pneumonia during serotype-1 (ST217) infection. We use BALB/c mice, which are highly resistant to pneumococcal pneumonia when infected with other serotypes. However, we observe 100% mortality and high levels of bacteraemia within 24 hours when BALB/c mice are intranasally infected with ST217. Serotype 1 produces large quantities of pneumolysin, which is rapidly released due to high levels of bacterial autolysis. This leads to substantial levels of cellular cytotoxicity and breakdown of tight junctions between cells, allowing a route for rapid bacterial dissemination from the respiratory tract into the blood. Thus, our results offer an explanation for the increased invasiveness of serotype 1
THE B LYMPHOCYTE DIFFERENTIATION FACTOR (BAFF) IS EXPRESSED IN THE AIRWAYS OF CHILDREN WITH CF AND IN LUNGS OF MICE INFECTED WITH PSEUDOMONAS AERUGINOSA
Background Chronic lung infection with Pseudomonas aeruginosa remains a major cause of mortality and morbidity among individuals with CF. Expression of mediators promoting recruitment and differentiation of B cells, or supporting antibody production is poorly understood yet could be key to controlling infection. Methods BAFF was measured in BAL from children with CF, both with and without P. aeruginosa, and controls. Mice were intra-nasally infected with P. aeruginosa strain LESB65 for up to 7 days. Cellular infiltration and expression of B cell chemoattractants and B cell differentiation factor, BAFF were measured in lung tissue. Results BAFF expression was elevated in both P. aeruginosa negative and positive CF patients and in P. aeruginosa infected mice post infection. Expression of the B cell chemoattractants CXCL13, CCL19 and CCL21 increased progressively post infection. Conclusions In a mouse model, infection with P. aeruginosa was associated with elevated expression of BAFF and other B cell chemoattractants suggesting a role for airway B cell recruitment and differentiation in the local adaptive immune response to P. aeruginosa. The paediatric CF airway, irrespective of pseudomonal infection, was found to be associated with an elevated level of BAFF implying that BAFF expression is not specific to pseudomonas infection and may be a feature of the CF airway. Despite the observed presence of a potent B cell activator, chronic colonisation is common suggesting that this response is ineffective
A New Class of Changing-Look LINERs
We report the discovery of six active galactic nuclei (AGN) caught "turning
on" during the first nine months of the Zwicky Transient Facility (ZTF) survey.
The host galaxies were classified as LINERs by weak narrow forbidden line
emission in their archival SDSS spectra, and detected by ZTF as nuclear
transients. In five of the cases, we found via follow-up spectroscopy that they
had transformed into broad-line AGN, reminiscent of the changing-look LINER
iPTF 16bco. In one case, ZTF18aajupnt/AT2018dyk, follow-up HST UV and
ground-based optical spectra revealed the transformation into a narrow-line
Seyfert 1 (NLS1) with strong [Fe VII, X, XIV] and He II 4686 coronal lines.
Swift monitoring observations of this source reveal bright UV emission that
tracks the optical flare, accompanied by a luminous soft X-ray flare that peaks
~60 days later. Spitzer follow-up observations also detect a luminous
mid-infrared flare implying a large covering fraction of dust. Archival light
curves of the entire sample from CRTS, ATLAS, and ASAS-SN constrain the onset
of the optical nuclear flaring from a prolonged quiescent state. Here we
present the systematic selection and follow-up of this new class of
changing-look LINERs, compare their properties to previously reported
changing-look Seyfert galaxies, and conclude that they are a unique class of
transients well-suited to test the uncertain physical processes associated with
the LINER accretion state.Comment: Submitted to ApJ, 31 pages, 17 Figures (excluding Appendix due to
file size constraints but will be available in electronic version
The Fast, Luminous Ultraviolet Transient AT2018cow: Extreme Supernova, or Disruption of a Star by an Intermediate-Mass Black Hole?
Wide-field optical surveys have begun to uncover large samples of fast (t_(rise) ≲ 5 d), luminous (M_(peak) 10 days. The spectrum remains extremely hot throughout its evolution, and the photospheric radius contracts with time (receding below R < 10^(14) cm after 1 month). This behaviour does not match that of any known supernova, although a relativistic jet within a fallback supernova could explain some of the observed features. Alternatively, the transient could originate from the disruption of a star by an intermediate-mass black hole, although this would require long-lasting emission of highly super-Eddington thermal radiation. In either case, AT 2018cow suggests that the population of fast luminous transients represents a new class of astrophysical event. Intensive follow-up of this event in its late phases, and of any future events found at comparable distance, will be essential to better constrain their origins
The First ALLWISE Proper Motion Discovery: WISEA J070720.50+170532.7
While quality checking a new motion-aware co-addition of all 12.5 months of Wide-field Infrared Survey Explorer (WISE) data, we found that the source WISE J070720.48+170533.0 moved 0".9 in six months. Backtracking this motion allowed us to identify this source as 2MASS J07071961+1705464, with several entries in the USNO B catalog. An astrometric fit to these archival data gives a proper motion of μ = 1793 ± 2 mas yr^(–1) and a parallax of ω = 35 ± 42 mas. Photometry from WISE, 2MASS, and the POSS can be fit reasonably well by a blackbody with T = 3658 K and an angular radius of 4.36 × 10^(–11) radians. No clear evidence of H_2 collision-induced absorption is seen in the near-infrared. An optical spectrum shows broad deep CaH bands at 638 and 690 nm, broad deep Na D at 598.2 nm, and weak or absent TiO, indicating that this source is an ultra-subdwarf M star with a radial velocity v_(rad) ≈ –21 ± 18 km s^(–1) relative to the Sun. Given its apparent magnitude, the distance is about 39 ± 9 pc and the tangential velocity is probably ≈330 km s^(–1), but a more precise parallax is needed to be certain
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly Inherited Alzheimer Network and ultrasensitive immunoassay technology to demonstrate that NfL levels in the cerebrospinal fluid (n = 187) and serum (n = 405) are correlated with one another and are elevated at the presymptomatic stages of familial Alzheimer's disease. Longitudinal, within-person analysis of serum NfL dynamics (n = 196) confirmed this elevation and further revealed that the rate of change of serum NfL could discriminate mutation carriers from non-mutation carriers almost a decade earlier than cross-sectional absolute NfL levels (that is, 16.2 versus 6.8 years before the estimated symptom onset). Serum NfL rate of change peaked in participants converting from the presymptomatic to the symptomatic stage and was associated with cortical thinning assessed by magnetic resonance imaging, but less so with amyloid-β deposition or glucose metabolism (assessed by positron emission tomography). Serum NfL was predictive for both the rate of cortical thinning and cognitive changes assessed by the Mini-Mental State Examination and Logical Memory test. Thus, NfL dynamics in serum predict disease progression and brain neurodegeneration at the early presymptomatic stages of familial Alzheimer's disease, which supports its potential utility as a clinically useful biomarker
- …
